Lee M Akst-Johns
This presentation will comprehensively review evaluation and management of laryngeal leukoplakia. Though white vocal fold lesions are common, management remains challenging; doing insufficient may allow precancerous lesions to progress, while doing an excessive amount of may create unnecessary dysphonia through scar. I will present a framework for management of leukoplakia which balances oncologic with functional outcomes with the goal of achieving disease control without creating scar. State-of-the-art advances in care of leukoplakia will be emphasized and surgical techniques discussed will include role of infusion, use of the KTP laser and micro flap resection of diseased epithelium. Advanced use of the KTP laser for office treatment of laryngeal dysplasia, a crucial a part of my very own practice and something which is merely available during a limited number of centres worldwide is going to be discussed also, to incorporate appropriate Anesthesia techniques for office based procedures. Epidemiology of leukoplakia, rates of progression to malignancy and role of office-based biopsy will be reviewed. Though focus are going to be on KTP laser strategies as these represent leading edge approached to management of this disease, i will be able to also discuss cold instrument and CO2 laser techniques so that the audience, regardless of the tools available to them in their own practices, will be able to transition techniques learned in this presentation to care of their own patients. Approaches to anterior commissure involvement, bilateral disease and multiply recurrent dysplasia are going to be discussed through case presentations which should increase audience interest.
Tracheo Bronchopathia Osteo Ch"art-12">The overall incidence of this disease varies as reported within the literature—on average 1:125 to 1:6000 cases during bronchoscopy . The presentation is often asymptomatic or may instead include nonspecific respiratory complaints, with cough and dyspnoea the most common. The etiology of TBOC is unclear, but it's considered secondary to chronic airway inflammation. The diagnosis is formed on bronchoscopic findings and sometimes, CT imaging of the chest, with little role in histopathology to verify findings aside from to exclude other pathologies. Treatment is symptomatic, ranging from cough suppression to excision and dilation depending on severity of the airway compromise.
In this report, we present a case of tracheobronchopathia osteochondroplastica found incidentally during a patient being managed for recurrent vocal fold leukoplakia and dysplasia. We review the clinical manifestations, diagnosis, pathophysiology and treatment for our patient with this rare disease.
A 77 year-old male presented with dysphonia and history of prior outside surgery for leukoplakia, with outside pathologic diagnosis of dysplasia. At time of presentation to our clinic, Tran’s oral stroboscope revealed scar of the right vocal fold consistent with his prior surgery and persistent/recurrent leukoplakia. The patient had no complaints of dyspnea, cough or inspiratory stridor. With persistent disease and desire to re-establish pathologic diagnosis, the patient was taken to the OR for suspension micro laryngoscopy and micro flap excision of diseased vocal cord epithelium. During micro laryngoscopy, views of the anterior subglottic demonstrated little nodular sub mucosal lesion along the anterior tracheal wall just beneath the cricoid cartilage. This anterior tracheal lesion was biopsied during the procedure. While the vocal cord leukoplakia was found on histopathology to be dysplasia without evidence of invasion, the ultimate pathology of the proximal tracheal lesion was chronic inflammation.
इस लेख का हिस्सा